Log in

Relevant bibliographies by topics / Cardiovascular prognosis

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Cardiovascular prognosis'

Author: Grafiati

Published: 4 June 2021

Last updated: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cardiovascular prognosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cardiovascular prognosis"

1

Mena, Luis J., Eber E. Orozco, Vanessa G. Felix, Rodolfo Ostos, Jesus Melgarejo, and Gladys E. Maestre. "Machine Learning Approach to Extract Diagnostic and Prognostic Thresholds: Application in Prognosis of Cardiovascular Mortality." Computational and Mathematical Methods in Medicine 2012 (2012): 1–6. http://dx.doi.org/10.1155/2012/750151.

Full text

Abstract:

Machine learning has become a powerful tool for analysing medical domains, assessing the importance of clinical parameters, and extracting medical knowledge for outcomes research. In this paper, we present a machine learning method for extracting diagnostic and prognostic thresholds, based on a symbolic classification algorithm called REMED. We evaluated the performance of our method by determining new prognostic thresholds for well-known and potential cardiovascular risk factors that are used to support medical decisions in the prognosis of fatal cardiovascular diseases. Our approach predicte

APA, Harvard, Vancouver, ISO, and other styles

2

Siasos, Gerasimos, Panagiota K. Stampouloglou, Evanthia Bletsa, et al. "SGLT-2i and Cardiovascular Prognosis." Current Pharmaceutical Design 26, no. 32 (2020): 3905–7. http://dx.doi.org/10.2174/138161282632200811172751.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Alieva, A. M., A. V. Sozykin, N. V. Teplova, et al. "Tenascin-C as a cardiovascular marker." Russian Journal of Cardiology 27, no. 8 (2022): 5150. http://dx.doi.org/10.15829/1560-4071-2022-5150.

Full text

Abstract:

Novel biological markers, such as fibrosis marker galectin-3, peptide hormone adrenomedullin, soluble ST2, chemokine CX3CL1, surrogate marker of vasopressin, and others, are every year one step closer to being introduced into health practice. Over the past decades, significant progress has been made in the study of cardiovascular biomarkers. A key moment was the introduction of deter mining the concentration of natriuretic peptides used as markers for the diagnostic and prognostic evaluation of patients with heart failure. Currently, in order to search for novel markers for early diagnosis and

APA, Harvard, Vancouver, ISO, and other styles

4

BUCH, HOLGER. "Prognosis of Late Syphilitic Cardiovascular Lesions." Acta Medica Scandinavica 122, no. 6 (2009): 529–39. http://dx.doi.org/10.1111/j.0954-6820.1945.tb04520.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Broadstone, V. L., T. Roy, M. Self, and M. A. Pfeifer. "Cardiovascular Autonomic Dysfunction: Diagnosis and Prognosis." Diabetic Medicine 8, S2 (1991): S88—S93. http://dx.doi.org/10.1111/j.1464-5491.1991.tb02165.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lauer, M. S. "Left ventricular hypertrophy and cardiovascular prognosis." Cleveland Clinic Journal of Medicine 62, no. 3 (1995): 169–75. http://dx.doi.org/10.3949/ccjm.62.3.169.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Espinola-Klein, Christine, Hans J. Rupprecht, Christoph Bickel, et al. "Inflammation, atherosclerotic burden and cardiovascular prognosis." Atherosclerosis 195, no. 2 (2007): e126-e134. http://dx.doi.org/10.1016/j.atherosclerosis.2007.01.021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kario, Kazuomi, Satoshi Hoshide, Hiroyuki Mizuno, et al. "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis." Circulation 142, no. 19 (2020): 1810–20. http://dx.doi.org/10.1161/circulationaha.120.049730.

Full text

Abstract:

Background: Ambulatory and home blood pressure (BP) monitoring parameters are better predictors of cardiovascular events than are office BP monitoring parameters, but there is a lack of robust data and little information on heart failure (HF) risk. The JAMP study (Japan Ambulatory Blood Pressure Monitoring Prospective) used the same ambulatory BP monitoring device, measurement schedule, and diary-based approach to data processing across all study centers and determined the association between both nocturnal hypertension and nighttime BP dipping patterns and the occurrence of cardiovascular eve

APA, Harvard, Vancouver, ISO, and other styles

9

Nakashima, Mitsutaka, Kazufumi Nakamura, Takahiro Nishihara, et al. "Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist." Nutrients 15, no. 3 (2023): 748. http://dx.doi.org/10.3390/nu15030748.

Full text

Abstract:

Cardiovascular diseases and liver diseases are closely related. Non-alcoholic fatty liver disease has the same risk factors as those for atherosclerotic cardiovascular disease and may also be a risk factor for atherosclerotic cardiovascular disease on its own. Heart failure causes liver fibrosis, and liver fibrosis results in worsened cardiac preload and congestion. Although some previous reports regard the association between cardiovascular diseases and liver disease, the management strategy for liver disease in patients with cardiovascular diseases is not still established. This review summa

APA, Harvard, Vancouver, ISO, and other styles

10

Cinza Sanjurgo, S., J. E. López Paz, A. Hermida Ameijeiras, et al. "ORGAN DAMAGE AND CARDIOVASCULAR PROGNOSIS IN HYPERTENSION." Journal of Hypertension 29 (June 2011): e256. http://dx.doi.org/10.1097/00004872-201106001-00717.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Cardiovascular prognosis"

1

Li, Sin Wan. "Development of immunoassays for prognosis and diagnosis of cardiovascular diseases /." View abstract or full-text, 2007. http://library.ust.hk/cgi/db/thesis.pl?CHEM%202007%20LI.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cremer, Paul C. "POOR PROGNOSIS ASSOCIATED WITH PHARMACOLOGIC TESTING AND LOWER EXERCISE CAPACITY IN PATIENTS REFERRED FOR STRESS TESTING." Case Western Reserve University School of Graduate Studies / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=case1548855325465571.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Gulati, Ankur. "The role of cardiovascular magnetic resonance in the characterisation and risk stratification of dilated cardiomyopathy." Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.607884.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Currie, Peter Fox. "The cardiovascular manifestations of human immunodeficiency virus infection and the acquired immunodeficiency syndrome : prevalence, prognosis and pathogenesis." Thesis, University of Aberdeen, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.287717.

Full text

Abstract:

The main aim of the work presented in this thesis was to delineate the natural history and pathogenesis of HIV related heart muscle disease. Additional studies examined the influence of HIV infection on the risk and course of infective endocarditis. Two hundred and ninety-six HIV positive adults were examined by echocardiography in a four year prospective study. Abnormal cardiac function was identified in 14.8%. Dilated cardiomyopathy was present in 4.4% borderline left ventricular dysfunction in 6.4% and isolated right ventricular dysfunction in 4%. Dilated cardiomyopathy was strongly associa

APA, Harvard, Vancouver, ISO, and other styles

5

Bao, Bingyuan. "β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction". Kyoto University, 2014. http://hdl.handle.net/2433/188674.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Yasуnska, E. Ts. "Assessment of the influence of psychological factors on the occurrence of adverse cardiovascular prognosis in patients with coronarysheart disease (CHD)." Thesis, БДМУ, 2021. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18862.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Björklund, Kristina. "24-hour Ambulatory Blood Pressure - Relation to the Insulin Resistance Syndrome and Cardiovascular Disease." Doctoral thesis, Uppsala University, Geriatrics, 2002. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2871.

Full text

Abstract:

<p>This study examined relationships between 24-hour ambulatory BP and components of the insulin resistance syndrome, and investigated the prognostic significance of 24-hour BP for cardiovascular morbidity in a longitudinal population-based study of 70-year-old men. The findings indicated, that a reduced nocturnal BP fall, nondipping, was a marker of increased risk primarily in subjects with diabetes. A low body mass index and a more favourable serum fatty acid composition at age 50 predicted the development of white-coat as opposed to sustained hypertension over 20 years. Furthermore, cross-s

APA, Harvard, Vancouver, ISO, and other styles

8

Yiin, Gabriel Shih Chung. "The prevalence, detection and prognosis of atrial fibrillation in patients with transient ischaemic attack and stroke." Thesis, University of Oxford, 2014. http://ora.ox.ac.uk/objects/uuid:c317f195-9a7e-4870-9b6a-a7de77e89198.

Full text

Abstract:

Stroke is a major cause of premature death and disability throughout the world and atrial fibrillation (AF) is one of the most common preventable causes of stroke. AF affects about 10% of individuals aged ≥80 years, but warfarin is substantially under-used in this age group despite being effective in preventing AF-related thromboembolic events. AF-related ischaemic strokes tend to be severe and incur high care costs, and non-cerebral systemic embolism secondary to AF is also a major clinical burden. Despite that, there are few population-based studies on AF-related ischaemic stroke, and no rec

APA, Harvard, Vancouver, ISO, and other styles

9

Freitas, Humberto Felício Gonçalves de. "Prognóstico em portadores de insuficiência cardíaca encaminhados para avaliação de tratamento cirúrgico." Universidade de São Paulo, 2002. http://www.teses.usp.br/teses/disponiveis/5/5131/tde-19082014-100741/.

Full text

Abstract:

O objetivo deste estudo foi avaliar o prognostico de portadores de insuficiência cardíacadoe diferentes etiologias, incluindo a Doença de Chagas, na década de noventa ern uma unica intituição. Foram avaliados 1 220 pacientes portadores de insuficiência cardíaca encaminhados para avaliação de tratamento cirúrgico, acompanhados por período de 25,6+- 26 meses. As idades variavarn entre 13 e 72 anos (45,5 +- 11 anos); 952 (78%) pacientes eram do sexo masculino e 268 (22%) do feminino.A insuficiência cardíaca foi considerada idiopática em 454 (37,2%) doentes. A etiologia da insuficiência cardiac

APA, Harvard, Vancouver, ISO, and other styles

10

Shiozaki, Afonso Akio. "Avaliação da fibrose miocárdica pela ressonância magnética e tomografia computadorizada com múltiplos detectores na cardiomiopatia hipertrófica." Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/5/5131/tde-27102011-170125/.

Full text

Abstract:

A cardiomiopatia hipertrófica (CMH) é uma doença cardíaca genética e se caracteriza como a principal causadora de morte súbita em jovens, com apresentação clínica variável, desde assintomáticos a morte súbita, o que dificulta sua estratificação de risco. Tanto a ressonância magnética cardiovascular (RMC) como a tomografia computadorizada com múltiplos detectores (TCMD) mostraram-se capazes de avaliar a fibrose miocárdica, que é frequentemente encontrada nos casos de CMH. Os objetivos desta tese são: avaliar a distribuição e a correlação entre as áreas de hipertrofia e fibrose miocárdica pela R

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Cardiovascular prognosis"

1

Luna, Antonio Bayés de. The surface electrocardiography in ischemic heart disease: Clinical and imaging correlations and prognostic implications. Blackwell Pub., 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

S, Kapoor Amar, and Singh B. N, eds. Prognosis and risk assessment in cardiovascular disease. Churchill Livingstone, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Olsson, B., and M. Schlepper. Cardiac Arrhythmias: Diagnosis Prognosis Therapy Proceedings 1st International Rytmonorm-Congress. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Olsson, B., and M. Schlepper. Cardiac Arrhythmias: Diagnosis Prognosis Therapy Proceedings 1st International Rytmonorm-Congress. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Wise, Matt, and Paul Frost. ICU treatment of cardiovascular failure. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0150.

Full text

Abstract:

Cardiovascular failure or shock is best defined as inadequate delivery or utilization of oxygen for cellular metabolic needs. The majority of shock states are characterized by limitations in perfusion rather than extraction of oxygen by tissues. It is important to recognize that ineffectual tissue perfusion may occur in the absence of hypotension and, therefore, a normal blood pressure does not exclude shock. This chapter covers the etiology of shock, as well as symptoms, complications, diagnosis, prognosis, and treatment.

APA, Harvard, Vancouver, ISO, and other styles

6

Deanfield, John E. Diurnal Distribution in Cardiovascular Disease: Prognosis and Therapy (Journal : Cardiology, Vol. 85, Supplement 2, 1994). S. Karger AG (Switzerland), 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

London, Gerard M. Cardiovascular complications in end-stage renal disease patients. Edited by Jonathan Himmelfarb. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0268.

Full text

Abstract:

Cardiovascular complications are the predominant cause of death in patients with end-stage renal disease (ESRD). The high incidence of cardiovascular complications results from pathology present before ESRD (generalized atherosclerosis, diabetes, hypertension) and an additive effect of multiple factors including haemodynamic overload and metabolic and endocrine abnormalities more or less specific to uraemia or its treatment modalities. These disorders are usually associated and can exacerbate each other. While ischaemic heart disease is a frequent cause of cardiac death, heart failure and sudd

APA, Harvard, Vancouver, ISO, and other styles

8

Peritoneal Carcinomatosis : Diagnosis and Treatment (Developments in Cardiovascular Medicine, 167). Springer, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Sinagra, Gianfranco, Marco Merlo, and Davide Stolfo. Dilated cardiomyopathy: clinical diagnosis and medical management. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0356.

Full text

Abstract:

Dilated cardiomyopathy (DCM) is a relatively rare primary heart muscle disease with genetic or post-inflammatory aetiology that affects relatively young patients with a low-risk co-morbidity profile. Therefore, DCM represents a particular heart failure model with specific characteristics and long-term evolution. The progressively earlier diagnosis derived from systematic familial screening programmes and the current therapeutic strategies have greatly modified the prognosis of DCM with a dramatic reduction of mortality over recent decades. A significant number of DCM patients present an impres

APA, Harvard, Vancouver, ISO, and other styles

10

Neiger, Jeffrey S., and Richard G. Trohman. Pathophysiology and management of electrocution. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0349.

Full text

Abstract:

Electrocution is a common source of morbidity and mortality, primarily affecting young children through accidents in the home and adults through occupational exposure. A familiarity with the basic principles of electrical physics helps elucidate the typical injuries sustained following electrical shock. Although death is a frequent result, patients successfully resuscitated following initial cardiopulmonary arrest often have a favourable prognosis. Survivors of electrocution may suffer injuries to a variety of organ systems, including the skin, cardiovascular system, and nervous system, and ar

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Cardiovascular prognosis"

1

Stanton, T., J. M. C. Connell, and J. J. V. McMurray. "Genetic Determinants of Susceptibility, Prognosis and Treatment in Heart Failure." In Cardiovascular Pharmacogenetics. Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-662-06214-2_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Specchia, Giuseppe, and Stefano Ghio. "Pathophysiology, Clinical Presentation, and Prognosis of Angina Pectoris." In Developments in Cardiovascular Medicine. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2628-5_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Bei, Yihua, Pujiao Yu, Dragos Cretoiu, Sanda Maria Cretoiu, and Junjie Xiao. "Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases." In Exosomes in Cardiovascular Diseases. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4397-0_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Levin, Adeera, Ognjenka Djurdjev, Brendan Barrett, et al. "Cardiovascular Disease in Patients with Chronic Kidney Disease: The Causes and Effects." In Improving Prognosis for Kidney Disorders. Springer Netherlands, 2002. http://dx.doi.org/10.1007/978-94-017-1848-6_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kemp, Harvey G. "Prognosis And Therapy In Patients With Angina And Normal Coronary Arteriograms." In Developments in Cardiovascular Medicine. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2596-7_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Boccara, F., C. Meuleman, S. Ederhy, et al. "Coronary Artery Disease in HIV-Infected Patients: ClinicalPresentation,Pathophysiology, Prognosis,Prevention,and Treatment." In Cardiovascular Disease in AIDS. Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kapoor, Anmol, Shreya Kapoor, Kamal Upreti, et al. "Cardiovascular Disease Prognosis and Analysis Using Machine Learning Techniques." In Communications in Computer and Information Science. Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-25088-0_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Zhang, Yi, Davide Agnoletti, Alexandra Yannoutsos, Michel E. Safar, and Jacques Blacher. "Blood Pressure Variability: Measurements, Influential Factors, Prognosis and Therapy." In Blood Pressure and Arterial Wall Mechanics in Cardiovascular Diseases. Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-5198-2_41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kumar, Rahul, Yogender Aggarwal, and Vinod Kumar Nigam. "Biomarkers and Heart Rate Variability in the Prognosis of Cardiovascular Disease: A Perspective." In Lecture Notes in Bioengineering. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-6915-3_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Cenko, E., B. Ricci, and R. Bugiardini. "STEMI: Prognosis." In Encyclopedia of Cardiovascular Research and Medicine. Elsevier, 2018. http://dx.doi.org/10.1016/b978-0-12-809657-4.99745-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cardiovascular prognosis"

1

Shahiduzzaman, Md, Nowreen Haque Biswas, Md Momin, and Raihan Sikdar. "Prognosis of Cardiovascular Disease Using Machine Learning Procedures." In 2022 International Conference on Advancement in Electrical and Electronic Engineering (ICAEEE). IEEE, 2022. http://dx.doi.org/10.1109/icaeee54957.2022.9836418.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Sabab, Shahed Anzarus, Md Ahadur Rahman Munshi, Ahmed Iqbal Pritom, and Shihabuzzaman. "Cardiovascular disease prognosis using effective classification and feature selection technique." In 2016 International Conference on Medical Engineering, Health Informatics and Technology (MediTec). IEEE, 2016. http://dx.doi.org/10.1109/meditec.2016.7835374.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Calero-Diaz, Hugo, David Chushig-Muzo, Himar Fabelo, Inmaculada Mora-Jimenez, Conceicao Granja, and Cristina Soguero-Ruiz. "Data-driven cardiovascular risk prediction and prognosis factor identification in diabetic patients." In 2022 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI). IEEE, 2022. http://dx.doi.org/10.1109/bhi56158.2022.9926871.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Graby, John, Jimena Soto-Hernaez, David Murphy, et al. "P2 BSCI/BSTI coronary artery calcification guidelines change management and predict prognosis regardless of age." In British Society of Cardiovascular Imaging Annual Meeting, Bath, 2022. BMJ Publishing Group Ltd and British Cardiovascular Society, 2022. http://dx.doi.org/10.1136/heartjnl-2022-bsci.7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Golyadkina, Anastasiya A., Aleksey A. Kalinin, Irina V. Kirillova, et al. "Patient-specific system for prognosis of surgical treatment outcomes of human cardiovascular system." In Saratov Fall Meeting 2014, edited by Elina A. Genina, Vladimir L. Derbov, Kirill V. Larin, Dmitry E. Postnov, and Valery V. Tuchin. SPIE, 2015. http://dx.doi.org/10.1117/12.2180033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ma, Chunhua. "Evaluation of APACHE Score and QT Interval Dispersion for the Prognosis of Critical Cardiovascular Diseases." In 2017 5th International Conference on Mechatronics, Materials, Chemistry and Computer Engineering (ICMMCCE 2017). Atlantis Press, 2017. http://dx.doi.org/10.2991/icmmcce-17.2017.137.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Shanmuganathan, Mayooran, Ambra Masi, Matthew K. Burrage, et al. "1 Long-term prognosis after acute ST-segment elevation myocardial infarction is determined by characteristics in both non-infarcted and infarcted myocardium on cardiovascular magnetic resonance imaging." In British Society of Cardiovascular Magnetic Resonance 2021 Annual Meeting. BMJ Publishing Group Ltd and British Cardiovascular Society, 2021. http://dx.doi.org/10.1136/heartjnl-2021-bscmr.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Gollmann-Tepeköylü, C., M. Thielmann, L. Pölzl, et al. "The Impact of Current Various Definitions of Perioperative Myocardial Infarction after Coronary Artery Bypass Grafting on Long-Term Prognosis." In 51st Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery (DGTHG). Georg Thieme Verlag KG, 2022. http://dx.doi.org/10.1055/s-0042-1742793.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Cleland, John, Aminat Shote, Suzanna Hardman, and Theresa McDonagh. "77 Contemporary prognosis of patients hospitalised with a primary diagnosis of heart failure: the national heart failure audit of england & wales." In British Cardiovascular Society Annual Conference ‘Digital Health Revolution’ 3–5 June 2019. BMJ Publishing Group Ltd and British Cardiovascular Society, 2019. http://dx.doi.org/10.1136/heartjnl-2019-bcs.75.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Xiong, Huiyi. "COVID-19 Comorbidities: How Do Underlying Hypertensive and Cardiovascular Conditions Affect the Prognosis and Therapies of COVID-19?" In International Conference on Health Big Data and Intelligent Healthcare. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011515700003438.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cardiovascular prognosis"

1

Wang, Xiao, Hong Shen, Yujie Liang, Yixin Wang, Meiqi Zhang, and Hongtao Ma. Effects of physical activity interventions for post-COVID-19 patients: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.5.0036.

Full text

Abstract:

Review question / Objective: Coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has caused a huge impact in many countries and has attracted great attention from countries around the world. However, since the outbreak of the COVID-19 pandemic, most attention has focused on containing transmission and addressing the surge of critically ill patients in acute care settings. As we enter the second phase of the pandemic, emphasis must evolve to post care of COVID-19 survivors. A variety of persistent sympto

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!